Next-generation investigational peptide studied for appetite regulation and metabolic health.
Retatrutide is studied as a multi-receptor agonist acting on GLP-1, GIP, and glucagon pathways. Research explores how this combined signaling may influence satiety, gastric emptying, glucose handling, and energy expenditure.
Protocol details are reviewed individually during your complimentary consultation.
Aurea Labs does not diagnose, treat, or prescribe. Any protocol should be discussed with a licensed healthcare professional.